Evaluation of the Impact of an Oral and Practical Presentation of Intrauterine Devices by a Health Professional on Women's Opinion as a Possible Contraceptive Method

Last updated: April 29, 2022
Sponsor: Raincy Montfermeil Hospital Group
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT05317715
GHT-GHI LRM-20220118
  • Ages 18-45
  • Female

Study Summary

Contraception among women in France has evolved considerably and has become a frequent reason for consultation in general practice in view of the growing shortage of gynaecologists practising in towns.

Intrauterine devices (IUDs) are the leading reversible contraceptive method used in the world, but only 20.7% of women in France were using them in 2010.

In practice, in France, use of the IUD is still "reserved" for older women or those who have already had children, despite medical recommendations.

In this study the investigator will investigate whether clear information about the mode of action and insertion/withdrawal of IUDs would dispel these misconceptions of patients.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Any woman aged 18 years and over who comes to a family planning centre
  • Having expressed her free and informed written consent
  • Affiliated to a social security scheme

Exclusion

Exclusion Criteria:

  • Women under 18 years of age
  • Woman with an IUD
  • Woman who has had an IUD before
  • Woman whose reason for consultation of the day is the insertion of an IUD
  • Menopausal woman
  • Woman who is infertile for any reason
  • Illiterate woman or woman who does not read French
  • Refusal to participate in the protocol
  • Incapable of age.
  • Pregnant or breastfeeding women
  • Vulnerable persons and protected persons as provided for in the Public Health CodePublic Health Code (articles L. 1121-5 to L.1121-8 and L.1122-1-2).

Study Design

Total Participants: 160
Study Start date:
April 14, 2022
Estimated Completion Date:
October 31, 2022

Study Description

Contraception among women in France has evolved considerably and has become a frequent reason for consultation in general practice in view of the growing shortage of gynaecologists practising in towns.

Intrauterine devices (IUDs) are the leading reversible contraceptive method used in the world, but only 20.7% of women in France were using them in 2010.

In practice in France, the use of IUDs is still "reserved" for older women or those who have already had children, despite medical recommendations. Indeed, there is a certain feeling of mistrust towards the IUD as a contraceptive method. Sometimes the patient's reasons for refusal were unclear or misconceptions and prejudices prevailed.

Various research studies and theses have identified the various obstacles to the use of the IUD as a contraceptive. Today it would be interesting to evaluate whether a short presentation of the IUD during a consultation would lead to a better acceptance of women to use it as a possible contraceptive method.

In this study the investigators will investigate whether clear information about the mode of action and insertion/removal of IUDs would dispel these misconceptions of patients.

Connect with a study center

  • Le Raincy Montfermeil hospital

    Montfermeil, 93370
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.